B. Metzler seel. Sohn & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,642
| Closed | -$281K | – | 781 |
|
|
2024
Q2 | $281K | Sell |
2,642
-1,927
| -42% | -$205K | ﹤0.01% | 713 |
|
|
2024
Q1 | $442K | Sell |
4,569
-2,082
| -31% | -$201K | ﹤0.01% | 628 |
|
|
2023
Q4 | $672K | Buy |
6,651
+718
| +12% | +$72.5K | 0.01% | 567 |
|
|
2023
Q3 | $604K | Hold |
5,933
| – | – | 0.01% | 559 |
|
|
2023
Q2 | $599K | Buy |
5,933
+736
| +14% | +$74.3K | 0.01% | 559 |
|
|
2023
Q1 | $478K | Sell |
5,197
-2,607
| -33% | -$240K | 0.01% | 560 |
|
|
2022
Q4 | $708K | Sell |
7,804
-617
| -7% | -$56K | 0.01% | 491 |
|
|
2022
Q3 | $640K | Buy |
8,421
+2,950
| +54% | +$224K | 0.01% | 504 |
|
|
2022
Q2 | $462K | Buy |
+5,471
| New | +$462K | 0.01% | 569 |
|
|
2021
Q2 | – | Sell |
-13,615
| Closed | -$1.16M | – | 703 |
|
|
2021
Q1 | $1.16M | Buy |
+13,615
| New | +$1.16M | 0.02% | 395 |
|